Rchr
J-GLOBAL ID:201901007616484869   Update date: Oct. 01, 2024

emika Ohkoshi

オオコシ エミカ | emika Ohkoshi
Research field  (1): Environmental and pharmaceutical development resources
Research theme for competitive and other funds  (7):
  • 2020 - 2025 学生エンゲージメントを促す薬学教育の実践
  • 2020 - 2023 ミトコンドリア機能と品質管理機構から捉える重症病態の分子病態研究
  • 2020 - 2023 Dental clinical application fo induction odontoblastic differentiation mechanism in Dental Pulp Stem Cells
  • 2017 - 2020 Clarification of metastasis development mechanism in oral cancer stem cell
  • 2017 - 2019 低酸素環境下における口腔癌のがん幹細胞に対する新規分子標的治療の開発
Show all
Papers (45):
  • Kuniko Kusama-Eguchi, Yuki Tokui, Ai Minoura, Yuta Yanai, Dai Hirose, Megumi Furukawa, Yasuhiro Kosuge, Motofumi Miura, Emika Ohkoshi, Mitsuko Makino, et al. 2(3H)-Dihydrofranolactone metabolites from Pleosporales sp. NUH322 as anti-amyotrophic lateral sclerosis drugs. Journal of natural medicines. 2024. 78. 1. 146-159
  • Koichi Murakami, Naoki Umemura, Makoto Adachi, Masahiro Motoki, Emika Ohkoshi. ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells. Experimental and therapeutic medicine. 2022. 24. 6. 722-722
  • Koji Wada, Masuo Goto, Emika Ohkoshi, Kuo-Hsiung Lee, Hiroshi Yamashita. Bioactivity inspired C19-diterpenoid alkaloids for overcoming multidrug-resistant cancer. Journal of natural medicines. 2022
  • Kunihiro Kajiura, Naoki Umemura, Emika Ohkoshi, Takahisa Ohta, Nobuo Kondoh, Satoshi Kawano. Shikonin induces odontoblastic differentiation of dental pulp stem cells via AKT-mTOR signaling in the presence of CD44. Connective tissue research. 2021. 1-9
  • Toshiyuki Nanbu, Naoki Umemura, Emika Ohkoshi, Kumi Nanbu, Hiroshi Sakagami, Jun Shimada. Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells. Oncology reports. 2018. 39. 1. 367-375
more...
MISC (81):
  • Satsuki Kishita, Naoki Umemura, Hiromi Miyazaki, Hideki Yagi, Emika Ohkoshi. Shikonin induce immunogenic cell death in multidrug resistant oral squamous cell carcinoma. 2024. 144年会. 31P-am070
  • Seika Horimatsu, Tomomi Tada, Hiroya Miura, Emika Ohkoshi. Cognitive biases influence the health awareness of local residents. 2024. 144年会. 30P-am-482
  • 堀松 星翔, 多田 智美, 水谷 征法, 天内 博康, 金光 兵衛, 三浦 裕也, 大越 絵実加. 中学生の「学びに向かう力」を養う理科実験プログラムの学習効果. 日本薬学教育学会. 2023. 第8回
  • 岸田 皐, 堀松 星翔, 多田 智美, 水谷 征法, 三浦 裕也, 大越 絵実加. 日常と関連した理科実験プログラムが中学生の科学的探究活 動に及ぼす効果の検証. 日本薬学教育学会. 2023. 第8回
  • 小笠原 玲生, 堀松 星翔, 岸田 皐, 多田 智美, 野上 光博, 人見 啓太朗, 石井 慶造, 大越 絵実加. 「持続可能な社会の創り手」の育成を目指すSDGsを意識した 小学校理科教材の開発. 日本薬学教育学会. 2023. 第8回
more...
Lectures and oral presentations  (1):
  • Development of inquiry-based learning materials using local resources
    (2024)
Education (2):
  • 1994 - 1996 Nihon University Graduate School of Pharmacy
  • 1989 - 1993 Nihon University School of Pharmacy
Professional career (1):
  • 博士(薬学) (日本大学)
Work history (3):
  • 2024/04 - 現在 International University of Health and Welfare Faculty of Pharmaceutical Sciences
  • 2020/04 - 2024/03 Aomori University Faculty of Pharmaceutical Sciences
  • 2015/04 - 2020/03 Aomori University Faculty of Pharmaceutical Sciences
Committee career (2):
  • 2017/04 - 2024/03 Commissioner of registered distributor
  • 2017/04 - 2024/03 The Japanese Society of Pharmacognosy Representative
Association Membership(s) (2):
The Pharmaceutical Society of Japan ,  The Japanese Society of Pharmacognosy
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page